Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lead Service Line Replacement Cost Calculator Featured on United Nations South-South Galaxy Platform
-
QGold Announces Acceleration of Warrant Expiry Dates
-
Repligen to Report First Quarter 2026 Financial Results
-
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
-
Arq Schedules First Quarter 2026 Earnings Conference Call
-
Habit Celebrates Newest Restaurant Launch in Reseda, California
-
LexisNexis® CounselLink® Releases 2026 Trends Report as Rising Rates and Big Law Share of Wallet Continue to Climb
-
Big Bear Gold Corp. Completes Shares for Debt Settlements
-
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
-
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
-
Holding(s) in Company
-
Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology
-
Caliber Advances Hyatt Studios Development Platform Across Three High-Growth Markets
-
Pecoy Copper Completes Magnetotelluric Survey to Optimize High-Priority Targeting and Resource Expansion
-
Growscape Launches Revolutionary EarthSafe Sustainability Platform, Setting New Industry Standard
-
Storaktionærmeddelelse
-
Landsbankinn hf.: Financial results for Q1 2026 to be published 30 April 2026
-
Balchem Corporation Releases 2025 Sustainability Report
-
Luminoah Announces FDA Clearance of the Luminoah Flow Enteral Nutrition System, A Brighter Future for Tube Feeding
-
From Lab to Field: HPQ and Novacium Secure First Battery Order from European Drone Manufacturer Using GEN4 Cells
-
Emerita Intersects High Grade Zone of 4.9m Containing Mineralization Grading 3.5% Copper, 1.95 g/t Gold and 95.63 g/t Silver at El Cura
-
NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs
-
Allpoints Services Names Longtime Homebuilding Executive John Ballard as CRO
-
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
-
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
-
Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026
-
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting
-
Fidelity D & D Bancorp, Inc. Reports First Quarter 2026 Financial Results
-
SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156
-
Lantronix to Report Fiscal 2026 Third Quarter Results on May 6, 2026
-
Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
-
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
-
EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting
-
Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026
-
Stifel Reports First Quarter 2026 Results
-
Advantage Solutions Announces Date for its First Quarter 2026 Financial Results and Conference Call
-
Rogers Communications Reports First Quarter 2026 Results
-
Aurora Mobile's EngageLab Redefines AI-Native Customer Engagement at NexTech Week Tokyo Spring 2026
-
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026
-
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
-
Sweet Harvest Foods and Nate’s Hives Awarded Three Recipients of the Inaugural Nate’s Hives Research Grant Program
-
SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026
-
NeurAxis Expands Payer Coverage with Four New Medical Policies
-
Old National Bancorp Reports First Quarter 2026 Results
-
Rafael Holdings Announces Patent Licensing Agreement with MIT for “Small Molecules to Improve Myelination in ApoE4 positive Alzheimer’s Disease”
-
BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026
-
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
-
Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting
-
The National Gallery of Art Receives Historic $116 Million Gift from the Mitchell P. Rales Family Foundation Endowing “Across the Nation” National Lending Program
-
Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting

